GLP-1s were originally designed for diabetes management under names like Victoza and Byetta, GLP-1 drugs are now marketed as weight loss solutions under names like Ozempic, Wegovy, and Rybelsus
The research, funded by a biotech called BlueWater Biosciences, would still need to be confirmed in humans
Plain, unmarked packaging no branding or product names on the outside
Piteau S, Olver A, Kim SJ, Winter K, Pospisilik JA, Lynn F, et al
What ties an untested powder to insulin and Ozempic is just the word they share: peptide. Thats the marketing
These commercial relationships do not influence the factual content or editorial integrity of the information provided, which is based on scientific literature, clinical understanding, and established biochemical mechanisms